Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cedric Hermans

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 14, 2020
Blood-induced cartilage damage alters the ankle joint load during walkingMaarten Eerdekens, Kathelijne Peerlinck, Filip Staes, et al.
Clinical Case Reports|April 19, 2019
Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continentsShannon Jackson, Cristina Santoro, Deborah Gue, et al.
European Journal of Haematology|June 14, 2016
Partnering to change the world for people with haemophilia: 6(th) Haemophilia Global Summit, Prague, Czech Republic, 24-26(th) September 2015Jan Astermark, Dan Hart, Sébastien Lobet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2024
Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY StudiesCedric Hermans, Mark W Skinner, Brittany Gentile, et al.
Health and Quality of Life Outcomes|March 20, 2020
Cross-cultural adaptation and validation of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in Côte d'Ivoire (the Ivory Coast)Catherine Lambert, N' Dogomo Meité, Ibrahima Sanogo, et al.
Research and Practice in Thrombosis and Haemostasis|February 14, 2023
Nonreplacement therapy for hemophilia in low-income countries: experience from a prospective study in Ivory CoastCatherine Lambert, N'Dogomo Meité, Gustave Koffi Kouassi, et al.
The Lancet. Haematology|August 8, 2024
Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines ListGlenn F Pierce, Brian O'Mahony, Radoslaw Kaczmarek, et al.
Research and Practice in Thrombosis and Haemostasis|April 28, 2025
Persisting thrombomodulin resistance at 3 months after liver transplantation in children with cirrhosisMarie-Astrid van Dievoet, Clara David, Audrey Dieu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2024
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia ASuresh Agarwal, Cedric Hermans, Wolfgang Miesbach, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2021
Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre's readiness in United States and EUWolfgang Miesbach, K John Pasi, Steven W Pipe, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 14, 2020
Blood-induced cartilage damage alters the ankle joint load during walkingMaarten Eerdekens, Kathelijne Peerlinck, Filip Staes, et al.
Clinical Case Reports|April 19, 2019
Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continentsShannon Jackson, Cristina Santoro, Deborah Gue, et al.
European Journal of Haematology|June 14, 2016
Partnering to change the world for people with haemophilia: 6(th) Haemophilia Global Summit, Prague, Czech Republic, 24-26(th) September 2015Jan Astermark, Dan Hart, Sébastien Lobet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2024
Pain-Related Quality of Life Outcomes in People With Haemophilia A Receiving Emicizumab: A Post Hoc Analysis of the HAVEN 1, 3 and 4 and STASEY StudiesCedric Hermans, Mark W Skinner, Brittany Gentile, et al.
Health and Quality of Life Outcomes|March 20, 2020
Cross-cultural adaptation and validation of the Canadian Haemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in Côte d'Ivoire (the Ivory Coast)Catherine Lambert, N' Dogomo Meité, Ibrahima Sanogo, et al.
Research and Practice in Thrombosis and Haemostasis|February 14, 2023
Nonreplacement therapy for hemophilia in low-income countries: experience from a prospective study in Ivory CoastCatherine Lambert, N'Dogomo Meité, Gustave Koffi Kouassi, et al.
The Lancet. Haematology|August 8, 2024
Risk of harm to people with haemophilia from the 2023 WHO Essential Medicines ListGlenn F Pierce, Brian O'Mahony, Radoslaw Kaczmarek, et al.
Research and Practice in Thrombosis and Haemostasis|April 28, 2025
Persisting thrombomodulin resistance at 3 months after liver transplantation in children with cirrhosisMarie-Astrid van Dievoet, Clara David, Audrey Dieu, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 29, 2024
Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia ASuresh Agarwal, Cedric Hermans, Wolfgang Miesbach, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 23, 2021
Evolution of haemophilia integrated care in the era of gene therapy: Treatment centre's readiness in United States and EUWolfgang Miesbach, K John Pasi, Steven W Pipe, et al.
Pageof 23